• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Sectors Health

NAFDAC issues public alert, recalls Juhel folic acid 5mg tablets over substandard quality 

Anthonia Obokoh by Anthonia Obokoh
June 2, 2025
in Health, Sectors
Steps to follow in getting a NAFDAC registration for your business in 2024
Share on FacebookShare on TwitterShare on Linkedin

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of one batch of Juhel Folic acid 5mg x1000 tablet, describing the product as substandard.

According to a statement published on the agency’s official website, the affected batch was identified during the Risk-Based Post Marketing Surveillance (PMS) conducted in February 2025.

Laboratory analysis revealed that the product did not meet the required quality standards.

“The product was found to be substandard following laboratory tests, which showed low active pharmaceutical ingredient (API) content,” NAFDAC stated.

The agency noted that a root cause analysis carried out by the manufacturer Juhel Pharma Ltd. attributed the problem to a malfunction in the weight adjuster device of the tableting machine, which led to inadequate API content. Consequently, the manufacturer initiated a recall of the affected batch.

“The product is Juhel Folic Acid 5mg x1000 tablets, with Lot Number 0531, manufactured by Juhel Pharma Ltd., 35 Nkwubor Road, Emene – Enugu,” the statement reads.

Public Alert No. 015/2025.
Recall of Substandard Juhel Folic Acid Tablets#NafdacALERTShttps://t.co/1Pvprt0xKn pic.twitter.com/jRYgjZ0Zuj

— NAFDAC NIGERIA (@NafdacAgency) June 2, 2025

Health risks of substandard medicines 

NAFDAC warned that administering substandard medicines poses significant risks to patient health and public health.

“These risks include poisoning, treatment failure, drug resistance, and even death.  

RelatedStories

No Content Available

“Substandard medicines may contain toxic substances, incorrect ingredients, or incorrect dosages, leading to severe adverse effects,” the agency said.

Folic acid is commonly used to treat or prevent folate deficiency anaemia and is especially critical during pregnancy, as it supports the proper development of the baby’s brain, skull, and spinal cord, helping to prevent neural tube defects such as spina bifida.

Agency moves to mop up affected products 

In response to the issue, NAFDAC said all zonal directors and state coordinators have been directed to conduct surveillance and remove the substandard product from circulation in their respective regions.

The agency urged distributors, retailers, healthcare professionals, and caregivers to be vigilant.

“All medical products must be obtained from authorized or licensed suppliers. The authenticity and physical condition of products should be carefully checked,” NAFDAC stated.

Healthcare professionals and consumers are encouraged to report any suspicion of substandard or falsified medicines to the nearest NAFDAC office.

More insights  

However, NAFDAC expressed concern following a recent alert from India’s Central Drugs Standard Control Organization (CDSCO), which flagged several pharmaceutical products as Not of Standard Quality (NSQ).

The declaration came after CDSCO conducted laboratory analysis on drug samples obtained from various sales and distribution points across India. The affected drugs failed to meet required quality standards and were formally designated as NSQ, signaling potential safety and efficacy risks.

NAFDAC noted that some of the pharmaceutical companies whose products were implicated in the CDSCO’s findings have subsidiaries, partners, or distributed products in Nigeria.

Among the companies involved are those with significant presence or partnerships in Nigeria, including firms like Abaris Healthcare Pvt Ltd, Alencure Biotech Pvt Ltd, Eurolife Healthcare Pvt Ltd, Health Biotech Ltd, HIGGS Healthcare, Kamataka Antibiotics & Pharmaceuticals Ltd (KAPL), Laborate Pharmaceuticals India Ltd, Legend Industries, Martins & Brown Biosciences Pvt Ltd., Mascot Health Series Pvt Ltd, Micron Pharmaceutical, Orison Pharma International, Rivpra Formulation Pvt Ltd, Sai Parenterals Ltd, Symbiosis Pharmaceuticals Pvt Ltd, Syncom Formulations (India) Ltd, and Zee Laboratories Ltd.


Follow us for Breaking News and Market Intelligence.
Tags: Juhel Pharma Folic Acid Quality IssueNAFDAC Juhel Folic Acid RecallRisk-Based Post Marketing Surveillance NAFDAC
Anthonia Obokoh

Anthonia Obokoh

Anthonia Obokoh is journalist with years experience in the media industry, focusing on health reporting. Known for her expertise as a health writer and analyst, she brings depth to topics from public health policies to healthcare advancements. Her work has earned her recognition as a trusted voice in Nigeria’s health journalism field.

Related Posts

No Content Available
Next Post
Presidency debunks claims of VP Shettima being barred from Aso Villa, labels reports “deliberate orchestration of falsehood” 

VP Shettima urges Vitol Group to back $25 billion Nigeria-Morocco Gas Pipeline

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank
Zenth Bank








DUNS

Recent News

  • Dove deodorant, soap pose harm to user’s reproductive system, unborn child- NAFDAC 
  • NIMC denies blocking Nigeria Police from accessing NIN database  
  • AI boom increasing tech sector’s carbon emission globally, says ITU  

Follow us on social media:

Recent News

Steps to follow in getting a NAFDAC registration for your business in 2024

Dove deodorant, soap pose harm to user’s reproductive system, unborn child- NAFDAC 

June 5, 2025
NIMC, world Bank

NIMC denies blocking Nigeria Police from accessing NIN database  

June 5, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics